Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
Go back to Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results| (NASDAQ: LRMR) | Delayed: 4.25 +0.19 (4.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.06 | 52 Week High | $ | |||
| Open | $4.19 | 52 Week Low | $ | |||
| Day High | $4.34 | P/E | N/A | |||
| Day Low | $4.17 | EPS | $ | |||
| Volume | 1,232,261 | |||||
| (NASDAQ: LRMR) | Delayed: 4.25 +0.19 (4.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.06 | 52 Week High | $ | |||
| Open | $4.19 | 52 Week Low | $ | |||
| Day High | $4.34 | P/E | N/A | |||
| Day Low | $4.17 | EPS | $ | |||
| Volume | 1,232,261 | |||||

